Search research articles
Contact Us
Filters
Showing results (111-120 of 176) with videos related to
Page
of 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2014
Angiogenic cytokines are antibody targets during graft-versus-leukemia reactions
Matthias Piesche, Vincent T Ho, Haesook Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 22, 2010
Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation
Philippe Armand, Haesook T Kim, Joanna Rhodes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 18, 2008
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome
Philippe Armand, Haesook T Kim, Vincent T Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 25, 2010
Donor-derived second hematologic malignancies after cord blood transplantation
Karen K Ballen, Corey Cutler, Beow Y Yeap, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 10, 2015
A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial
John Koreth, Haesook T Kim, Paulina B Lange, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 28, 2014
Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease
Caron A Jacobson, Lixian Sun, Haesook T Kim, et al.
Blood Advances
|
January 26, 2021
Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide
Benedetta Rambaldi, Haesook T Kim, Carol Reynolds, et al.
Blood Advances
|
September 4, 2020
Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia
Haesook T Kim, Conner J Shaughnessy, Sharmila C Rai, et al.
Bone Marrow Transplantation
|
October 12, 2020
Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease
Natasha Kekre, Haesook T Kim, Julia Hofer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 13, 2008
Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning
Philippe Armand, Supriya Gannamaneni, Haesook T Kim, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 176) with videos related to
Sort By:
Page
of 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2014
Angiogenic cytokines are antibody targets during graft-versus-leukemia reactions
Matthias Piesche, Vincent T Ho, Haesook Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 22, 2010
Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation
Philippe Armand, Haesook T Kim, Joanna Rhodes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 18, 2008
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome
Philippe Armand, Haesook T Kim, Vincent T Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 25, 2010
Donor-derived second hematologic malignancies after cord blood transplantation
Karen K Ballen, Corey Cutler, Beow Y Yeap, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 10, 2015
A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial
John Koreth, Haesook T Kim, Paulina B Lange, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 28, 2014
Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease
Caron A Jacobson, Lixian Sun, Haesook T Kim, et al.
Blood Advances
|
January 26, 2021
Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide
Benedetta Rambaldi, Haesook T Kim, Carol Reynolds, et al.
Blood Advances
|
September 4, 2020
Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia
Haesook T Kim, Conner J Shaughnessy, Sharmila C Rai, et al.
Bone Marrow Transplantation
|
October 12, 2020
Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease
Natasha Kekre, Haesook T Kim, Julia Hofer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 13, 2008
Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning
Philippe Armand, Supriya Gannamaneni, Haesook T Kim, et al.
Page
of 18